Clifford Roy Elcombe
Corporate Officer/Principal chez University Of Dundee
Profil
Clifford Roy Elcombe is the founder of CXR Biosciences Ltd., a company founded in 2001.
He held the title of Research Director from 2011 to 2016.
Currently, Dr. Elcombe is a Professor at the University of Dundee, a position he has held since 2012.
Previously, he worked as a Senior Scientist at Zeneca, Inc. Dr. Elcombe obtained his undergraduate and doctorate degrees from the University of Surrey.
Postes actifs de Clifford Roy Elcombe
| Sociétés | Poste | Début |
|---|---|---|
| University Of Dundee | Corporate Officer/Principal | - |
Anciens postes connus de Clifford Roy Elcombe
| Sociétés | Poste | Fin |
|---|---|---|
CXR Biosciences Ltd.
 CXR Biosciences Ltd. Pharmaceuticals: MajorHealth Technology CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom. | Fondateur | 25/08/2016 |
| Zeneca, Inc. | Corporate Officer/Principal | - |
Formation de Clifford Roy Elcombe
| University of Surrey | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CXR Biosciences Ltd.
CXR Biosciences Ltd. Pharmaceuticals: MajorHealth Technology CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom. | Health Technology |
| Zeneca, Inc. |
